Further research is needed to determine whether the anti-inflammatory effects of GLP-1 analogs are more pronounced compared to DPP4i, though the identified effects on TNF, IL1B and IL6 do provide overlap with those pathways engaged in RA, and provide an area of focus for future studies. This evidence concerns the gene IL6 and rheumatoid arthritis.